We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Versatile Modified Mass Spectrometry

By Biotechdaily staff writers
Posted on 22 Jun 2005
To make the methodology more useful for drug developers, researchers have modified the electrospray ionization component of a high-throughput mass spectrometer so that the sample aerosolization and protein charging processes are separated, which allows the instrument to operate at low voltages with a wide range of solvents. More...


Electrospray ionization is a technique used in mass spectrometry to overcome the propensity of macromolecules to fragment. In electrospray ionization a liquid is pushed through a very small charged metal capillary by a carrier gas. The liquid contains the substance which is to be studied, the analyte, as well as a large amount of solvent, which is usually much more volatile than the analyte. The charge contained in the capillary transfers to the liquid, which charges the analyte molecule. As like charges repel, the liquid pushes itself out of the capillary and forms a mist or an aerosol of small droplets about 10 µm across, to increase the distance between the similarly charged molecules.

A neutral carrier gas is sometimes used to evaporate the neutral solvent in the small droplets; this in turn brings the charged analyte molecules closer together. The proximity of the molecules becomes unstable, however, and as the similarly charged molecules come closer together, the droplets once again explode. This process repeats itself until the analyte is free of solvent and is a lone ion. The lone ion will then continue along to the mass analyzer.

Investigators at the Georgia Institute of Technology (Atlanta, USA) have developed the AMUSE (array of micromachined ultrasonic electrospray) technology, which they maintain has several advantages over classical electrospray ionization for the separation of proteins. The sample aerosolization and protein charging processes have been separated, giving AMUSE the ability to operate at low voltages with a wide range of solvents. In addition, AMUSE is a nanoscale ion source that can handle much smaller volumes of sample. The description of AMUSE in the May 16, 2005, issue of Applied Physics Letters, holds out the possibility that the expensive electrospray ionization component may be produced cheaply in a disposable format. This would open up new applications for the device in the fields of drug development and clinical diagnostics.




Related Links:
Georgia Institute of Technology

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automatic CLIA Analyzer
Shine i6000
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.